ORIC Pharmaceuticals Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About ORIC Pharmaceuticals Inc
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
/ 
Frequently asked questions
To buy ORIC Pharmaceuticals Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for ORIC Pharmaceuticals Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for ORIC Pharmaceuticals Inc is ORIC:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
ORIC Pharmaceuticals Inc has its primary listing on NASDAQ. You can trade ORIC Pharmaceuticals Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, ORIC Pharmaceuticals Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include ORIC Pharmaceuticals Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like ORIC Pharmaceuticals Inc.